Shares in the EV maker fell after a much-hyped event was heavier on showbiz than financial details.
Related Posts
Regeneron, Sanofi Get FDA OK for Dupixent to Treat COPD
Regeneron Pharmaceuticals and Sanofi have won FDA expanded approval of their blockbuster anti-inflammatory drug Dupixent in chronic obstructive pulmonary disease.
Financial Services Roundup: Market Talk
Find insight on Toronto-Dominion Bank, Man Group, Liontrust Asset Management and more in the latest Market Talks covering Financial Services.
BNP Paribas in Exclusive Talks for AXA’s Investment-Management Arm
BNP Paribas entered into exclusive talks to buy the investment-management arm of insurer AXA and reach a long-term partnership for 5.1 billion euros ($5.52 billion), […]